GW642444
Drug timelines are a Plus or Pro feature.
25 regulatory and trial events tracked for GW642444, covering 2013-08-08 to 2018-02-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]